Clinical Utility of the Liquid Biopsy in Biomarker-Guided Therapy
Traditional tissue genotyping is often limited by insufficient tumour tissue, heterogeneity and risks associated with serial tumour biopsies. Exploring the use of blood-based cancer genomics and biomarker-guided therapy is warranted.
Translations available below :
Report a problem
Is this content inappropriate?